This session presents the latest in comparative science showcasing the evidence-based process that informs our practice.Scheduled Interactive SessionMeet the Trialists: 11:00 AM EDT, Friday, May 8, 2020To attend the scheduled sessions, please log in to Heart Rhythm 365.
Moderator: Andrew D. Krahn, MD, FHRS, Division of Cardiology University of British Columbia, Vancouver, BC, Canada
Commentators: Sana M. Al-Khatib, MD, MHS, FHRS, CCDS Duke University Medical Center, Durham, NC Eric N. Prystowsky, MD, FHRS St. Vincent Hospital and Health Center, Indianapolis, IN
LBCT & Submitting Authors
Bruce S. Stambler. MD, FHRS, Piedmont Heart Institute, Atlanta, GA
Reinoud Knops, MD, PhD, Academic Medical Center, Hilversum, Netherlands
David De Lugio, MD, FHRS, Emory Saint Joseph`s Hospital, Atlanta, GA
Moussa Mansour, MD, FHRS, Massachusetts General Hospital, Boston, MA
Zhan Shi, MD, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China
Moderator A. D. Krahn: Honoraria/Speaking/Consulting Fee - Medtronic.
CommentatorsS. M. Al-Khatib: Honoraria/Speaking/Consulting Fee - Milestone Pharmaceuticals; Medtronic.E. N. Prystowsky: Honoraria/Speaking/Consulting Fee - CardioNet, Inc.; Medtronic. Stock or Stock Options - Public - Stereotaxis, Inc..
Presenters:
B.S. Stambler: Honoraria/Speaking/Consulting Fee: Boston Scientific, Milestone. Research (Contracted Grants for PIs and Named Investigators only): Biotronik, Milestone
R. Knops: Honoraria/Speaking/Consulting Fee, Cairdac, Medtonic, Boston Scientific, Abbott. Stock or Stock Options: AtaCor Medical Inc.
D. De Lugio: Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, AtriCure Inc
M. Mansour: Research (Contracted Grants for PIs and Name Only: Abbott, Biosense Webster. Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster. Stock or Stock Options: NewPace Ltd
Z. Shi: Nothing to Disclose